Quantinno Capital Management
EVH icon

Quantinno Capital Management’s Evolent Health EVH Stock Holding History

Quantinno Capital Management’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$109K Sell
31,262
-69,634
-69% -$309K ﹤0.01% 3561
2026
Q2 		$547K Buy
+100,896
New +$387K ﹤0.01% 2938
2026
Q1 		– Sell
-40,352
Closed -$161K – 3328
2025
Q4 		$161K Buy
40,352
+15,746
+64% +$87.5K ﹤0.01% 3088
2025
Q3 		$208K Buy
+24,606
New +$239K ﹤0.01% 2735

Other funds holding EVH

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Rubicon Founders
Rubicon Founders Nashville, Tennessee $147M AUM 17% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $114B AUM 35.47% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Rock Point Advisors
Rock Point Advisors Burlington, Vermont $402M AUM 17.12% 1-Year Est. Return

Quantinno Capital Management's EVH Position: Q3 2026 in Review

Quantinno Capital Management reduced its Evolent Health (EVH) stake by 69% in Q3 2026, selling an estimated $309K and leaving 31,262 shares worth $109K. The position accounts for ﹤0.01% of the portfolio, ranked #3561.

Quantinno Capital Management first reported a position in EVH in Q3 2025 and has held it in 4 quarters since. The position peaked at $547K in Q2 2026. 129 funds tracked by Wall St. Rank hold EVH as of Q3 2026.

  • Quantinno Capital Management held 31,262 shares of Evolent Health worth $109K as of Q3 2026.
  • Quantinno Capital Management sold 69,634 Evolent Health shares in Q3 2026, an estimated $309K.
  • Evolent Health made up ﹤0.01% of Quantinno Capital Management's portfolio in Q3 2026, its #3561 holding.
  • Quantinno Capital Management first reported a position in Evolent Health in Q3 2025 and has held it in 4 quarters since.
  • Quantinno Capital Management's Evolent Health position peaked at $547K in Q2 2026.
  • 129 funds tracked by Wall St. Rank held Evolent Health as of Q3 2026.

Based on Quantinno Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.